These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8827959)

  • 21. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
    Bardhan KD; Dallaire C; Eisold H; Duggan AE
    Gut; 1997 Aug; 41(2):181-6. PubMed ID: 9301496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
    Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
    Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 28. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
    Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quadruple therapy is more effective against H. pylori].
    Oberhofer E
    MMW Fortschr Med; 2016 May; 158(9):20. PubMed ID: 27155683
    [No Abstract]   [Full Text] [Related]  

  • 30. [Management of the peptic ulcer patient in the Helicobacter pylori age].
    Marshall BJ
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():36-40. PubMed ID: 7914434
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.
    Gisbert JP; Pajares JM; Valle J
    Helicobacter; 1999 Mar; 4(1):58-66. PubMed ID: 10352089
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of Helicobacter pylori-positive peptic ulcer disease.
    Malfertheiner P
    Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
    [No Abstract]   [Full Text] [Related]  

  • 34. Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.
    Adamek RJ; Opferkuch W; Wegener M
    Am J Gastroenterol; 1995 Jan; 90(1):168-9. PubMed ID: 7801936
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 36. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
    Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.
    Burette A; Glupczynski Y
    Infection; 1995; 23 Suppl 1():S44-52. PubMed ID: 7782116
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 39. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP; Gonzalez L; Calvet X
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
    Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
    Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.